Galectin Therapeutic (GALT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2018 | 06-2018 | 03-2018 | 12-2017 | 09-2017 | |
| Operating Expenses | 2,680 | 3,759 | 4,178 | 2,373 | 4,414 |
| Operating Income | -2,680 | -3,759 | -4,178 | -2,373 | -4,414 |
| Interest Expense | 87 | 85 | 84 | 0 | 0 |
| Other Income | 15 | 4 | 4 | -9 | 6 |
| Pre-tax Income | -2,752 | -3,840 | -4,258 | -2,382 | -4,408 |
| Net Income Continuous | -2,752 | -3,840 | -4,258 | -2,382 | -4,408 |
| Net Income | $-2,752 | $-3,840 | $-4,258 | $-2,382 | $-4,408 |
| EPS Basic Total Ops | -0.07 | -0.11 | -0.12 | -0.07 | -0.13 |
| EPS Basic Continuous Ops | -0.07 | -0.10 | -0.11 | -0.06 | -0.13 |
| EPS Diluted Total Ops | -0.07 | -0.11 | -0.12 | -0.07 | -0.13 |
| EPS Diluted Continuous Ops | -0.07 | -0.10 | -0.11 | -0.06 | -0.13 |
| EBITDA(a) | $-2,680 | $-3,759 | $-4,178 | $-2,373 | $-4,414 |